Login / Signup
Dolutegravir use in combination with rifampicin-based tuberculosis therapy: 3 years of real-world experience in a large UK teaching hospital.
Muge Cevik
Hugh McGann
Published in:
Sexually transmitted infections (2018)
Keyphrases
</>
mycobacterium tuberculosis
pulmonary tuberculosis
antiretroviral therapy
hiv aids
hiv infected patients
cross sectional
stem cells
human immunodeficiency virus
mesenchymal stem cells
electronic health record